Migraine Nervous System Diseases Migraine
Conditions
Interventions
The 140 migraine sufferers are randomly allocated to two different groups:
1. Treatment group: At least three acupuncture sessions per week and placebo medicine once a day for 4 weeks.
Sponsors
The Beijing Administration of Traditional Chinese Medicine (China)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients suffering from migraine without frequent aura (more than 2 migraine attacks in 4 weeks), diagnosed according to criteria of the International Headache Society 2. Male or female 3. Aged 18-65 years 4. Patients who had not used acupuncture or drugs with migraine prophylactic effects within the last 3 months
Exclusion criteria
Exclusion criteria: 1.Tension-type headache, Cluster headache and other primary headaches 2. Secondary headache and other neurological diseases 3. Neuralgia of the face or head 4. Pregnancy, nursing mother or insufficient contraception 5. Use of prophylactic migraine medication in the last 3 months 6. Therapy with beta-blocker in the last 3 months 7. Intake of antipsychotic or antidepressant drugs 8. Participation in another clinical trial 9. Have family history of depression, Parkinson?s disease and other extrapyramidal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of acupuncture for migraine prophylaxis was assessed by the following: 1. Visual Analogue Scale (VAS) to assess the severity of migraine pain 2. Short-From of McGill Pain Questionnaire (SF-MPQ) 3. Change in frequency and duration of migraine attacks The outcome measures above will be assessed before the treatment, at 1 week, 2 and 4 weeks during the treatment, and then every month for 3 months. If necessary, the assessments will be repeated 6 months after the treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Intake of acute-medication 2. Severity of adverse effects 3. Change in the frequency of nausea, vomiting and other correlative symptoms The outcome measures above will be assessed before the treatment, at 1 week, 2 and 4 weeks during the treatment, and then every month for 3 months. If necessary, the assessments will be repeated 6 months after the treatment. | — |
Countries
China
Outcome results
None listed